TY - JOUR
T1 - Reasons for discordance between positron emission tomography (PET) myocardial perfusion imaging (MPI) results and subsequent management
AU - Thomas, Merrill
AU - Spertus, John A.
AU - Kennedy, Kevin F.
AU - Thompson, Randall C.
AU - Chan, Paul S.
AU - Bateman, Timothy M.
AU - Patel, Krishna K.
N1 - Funding Information:
Drs. Thomas and Patel are supported by the National Heart, Lung, and Blood Institutes of Health Under Award Number T32HL110837; the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Chan is supported by National Heart, Lung, and Blood Institutes of Health Under Award Number 1R01HL123980 and serves as a consultant for Optum Rx and the American Heart Association. Dr. Spertus reports personal fees from Amgen, personal fees from Bayer, personal fees from Merck, personal fees from Novartis, personal fees from Janssen, personal fees from Myokardia, personal fees from Blue Cross Blue Shield of Kansas City, outside the submitted work. In addition, Dr. Spertus has a patent Copyright to the KCCQ with royalties paid and Equity in Health Outcomes Sciences. Dr. Bateman receives research grant support from Astellas and GE Healthcare. He serves as a consultant for AstraZeneca, Curium and GE Healthcare. He has an equity interest in Cardiovascular Imaging Technologies. He has intellectual property rights for Imagen PET and SPECT software.
Publisher Copyright:
© 2021, American Society of Nuclear Cardiology.
PY - 2022/6
Y1 - 2022/6
N2 - Background: Referral patterns to coronary angiography following positron emission tomography (PET) myocardial perfusion imaging (MPI) and reasons for non-referral following abnormal PET MPI are largely unknown. Methods: Referral rates to coronary angiography within 90 days post PET MPI were determined. A random subset of 100 patients with severe (≥ 10%) ischemia on MPI between 2014-16 who were not referred for angiography were examined to better understand reasons as to why patients with high-risk MPI findings did not undergo coronary angiography. Results: Among 19,282 unique patients, overall rate of 90-day coronary angiography was 18.5% (3574/19282). Among patients with severe ischemia, 64.1% (1930/3011) underwent angiography within 90 days; the rate was lower in those with mild-moderate (20.6% [1010/4898]) and no ischemia (5.6% [634/11373]). In the random sample of 100 patients, the most common physician reasons for non-referral were uncertainty regarding whether the test results were responsible for the patient’s presenting symptoms, renal failure, and patient age, frailty, or cognitive status, while patient preference for medical management was by far the most common patient reason. Conclusion: Referral rates for coronary angiography after PET correlate with severity of ischemia. However, there appear to be opportunities to reconsider testing for instances when results will not change clinical management.
AB - Background: Referral patterns to coronary angiography following positron emission tomography (PET) myocardial perfusion imaging (MPI) and reasons for non-referral following abnormal PET MPI are largely unknown. Methods: Referral rates to coronary angiography within 90 days post PET MPI were determined. A random subset of 100 patients with severe (≥ 10%) ischemia on MPI between 2014-16 who were not referred for angiography were examined to better understand reasons as to why patients with high-risk MPI findings did not undergo coronary angiography. Results: Among 19,282 unique patients, overall rate of 90-day coronary angiography was 18.5% (3574/19282). Among patients with severe ischemia, 64.1% (1930/3011) underwent angiography within 90 days; the rate was lower in those with mild-moderate (20.6% [1010/4898]) and no ischemia (5.6% [634/11373]). In the random sample of 100 patients, the most common physician reasons for non-referral were uncertainty regarding whether the test results were responsible for the patient’s presenting symptoms, renal failure, and patient age, frailty, or cognitive status, while patient preference for medical management was by far the most common patient reason. Conclusion: Referral rates for coronary angiography after PET correlate with severity of ischemia. However, there appear to be opportunities to reconsider testing for instances when results will not change clinical management.
UR - http://www.scopus.com/inward/record.url?scp=85131181606&partnerID=8YFLogxK
U2 - 10.1007/s12350-021-02695-7
DO - 10.1007/s12350-021-02695-7
M3 - Article
C2 - 34169476
AN - SCOPUS:85131181606
VL - 29
SP - 1109
EP - 1116
JO - Journal of Nuclear Cardiology
JF - Journal of Nuclear Cardiology
SN - 1071-3581
IS - 3
ER -